Forty-eight patients with endoscopically proven duodenal ulcer (DU) and Helicobacter pylori
infection detected by 14C-urea breath test (BT) were assigned to 5 days of treatment with …

The decision to treat a patient should in general always be based on potential risk and
advantage. Widespread and uncontrolled use of all kinds of anti-H. pylori regimens may …

Background Helicobacter pylori, NSAID and cigarette smoking are major risk factors for
gastroduodenal ulcers. However, the results of studies on the interaction between these …

Objectives: Among patients with peptic ulcer disease, the prevalence of Helicobacter pylori
has been reported to range from 80% to 90%. Thus empirical cost-effective therapy has …

Helicobacter pylori is associated with diffuse superficial gastritis and is one of the dominant
causal factors for duodenal ulcer disease. More recent knowledge has revealed that apart …

In the past five years 12 patients have been identified presenting with chronic duodenal
ulcer (DU) disease and with no evidence of current or recent Helicobacter pylori (H pylori) …

Objectives: To document the epidemiology of Helicobacter pylori infection in a normal
population, to assess asymptomatic H. pylori positive individuals for the presence of …

SUMMARY H. pylori is undoubtedly the dominant factor in the multifactorial peptic ulcer
diathesis. We should not ignore the other contributing factors but rather try to identify how …

BACKGROUND & AIMS: Infection with Helicobacter pylori (H pylori) is a risk factor for peptic
ulcer disease (PUD), but there are limited longitudinal data on the associations between …

Although several duodenal ulcer disease-specific abnormalities in gastric function have
been described (eg exaggerated gastrin releasing peptide-stimulated acid secretion and an …